Ace Therapeutics provides ADME & DMPK study services for antidiabetic drugs, including in vitro ADME and in vivo drug metabolism, as well as bioanalysis. We have extensive experience in antidiabetic drug development and can provide expert solutions in ADME/DMPK studies. Our one-stop services provide the expertise and reliable data needed to integrate projects to guide your antidiabetic drug development program to success.
ADME (absorption, distribution, metabolism and excretion) and DMPK (drug metabolism and pharmacokinetics) studies of antidiabetic drugs are an important part of the drug development process. These studies help to understand the behavior of the drug in the body, including how the drug is absorbed, how it is distributed in the body, how it is metabolized and ultimately how it is excreted from the body.
We offer a portfolio of in vitro ADME analysis services to help you predict the ADME (Absorption, Distribution, Metabolism and Excretion) properties of your antidiabetic drug candidates. Our comprehensive ADME strategies pay close attention to the molecular properties of antidiabetic drug candidates at all stages of drug development, with the aim of increasing the success of drug development.
|
|
|
|
|
|
|
|
We are experienced in in vivo pharmacokinetic and metabolic studies. Our in vivo proof-of-concept tests and model development are aimed at confirming the drug delivery, efficacy and tolerability properties of antidiabetic drug candidates in rodents and rabbits.
Ace Therapeutics designs customized in vivo and in vitro assays to assist clients with ADME & DMPK studies based on their needs. Our flexible service model allows us to perform ADME/DMPK analyses at different stages of drug development, reducing the risk of antidiabetic drug candidates with efficient and cost-effective services.
Ace Therapeutics has an experienced team of ADME, DMPK and medicinal chemistry experts. We are committed to creating value for our partners' antidiabetic drug development programs quickly and consistently. Please contact us for more details. We will work with you to drive innovation in diabetes R&D.
Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.